Everolimus-13C2,d4, CAS [[1661009-29-5]] Preis auf Anfrage

Catalog Number: MCE-HY-10218S1
Article Name: Everolimus-13C2,d4, CAS [[1661009-29-5]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-10218S1
Supplier Catalog Number: HY-10218S1
Alternative Catalog Number: MCE-HY-10218S1-1UNIT
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: RAD001-13C2,d4, SDZ-RAD-13C2,d4
Everolimus-13C2,d4 (RAD001-13C2,d4) is 13C labeled Everolimus. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2].
Molecular Weight: 964.23
CAS Number: [1661009-29-5]
Formula: C51 13C2H79D4NO14
Target: Apoptosis,Autophagy,Bacterial,FKBP,Isotope-Labeled Compounds,mTOR
Application Notes: MCE Product type: Isotope-Labeled Compounds